Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Plos One|March 26, 2019
Limited differential expression of miRNAs and other small RNAs in LPS-stimulated human monocytesDaniel Lu, Tracy Yamawaki, Hong Zhou, et al.Hybridoma (2005)|June 27, 2006
Generation and characterization of monoclonal antibodies to human keratinocyte growth factor receptorPing Wei, Jinghui Zhan, Shuying Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal CancerRafael G Amado, Michael Wolf, Marc Peeters, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2008
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancerRafael G Amado, Michael Wolf, Marc Peeters, et al.Molecular Cancer Therapeutics|February 4, 2010
Biochemical characterization of AMG 102: a neutralizing, fully human monoclonal antibody to human and nonhuman primate hepatocyte growth factorTeresa L Burgess, Jan Sun, Susanne Meyer, et al.Diabetes|February 13, 2016
Haploinsufficiency of the Insulin Receptor in the Presence of a Splice-Site Mutation in Ppp2r2a Results in a Novel Digenic Mouse Model of Type 2 DiabetesMichelle Goldsworthy, Ying Bai, Chi-Ming Li, et al.The New England Journal of Medicine|July 4, 2008
Motesanib diphosphate in progressive differentiated thyroid cancerSteven I Sherman, Lori J Wirth, Jean-Pierre Droz, et al.Journal of Lipid Research|November 1, 2008
Identification of three loci affecting HDL-cholesterol levels in a screen for chemically induced recessive mutations in miceTodd Juan, Murielle M Véniant, Joan Helmering, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro propertiesJosette Carnahan, Paul Wang, Richard Kendall, et al.The Journal of Biological Chemistry|July 26, 2002
The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathwayAlice J Chen, Guisheng Zhou, Todd Juan, et al.Pageof 3